Sort
40,608 grants matching “prostate cancer”
Administrative Core
$353,368Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2024 · CA
Heat shock proteins in cancer and signaling
$353,362Michael Y Sherman · Boston University Medical Campus · R01 · FY2006 · CA
iMRI Methods for Cancer Diagnosis and Treatment
$353,352Stanford University · R01 · FY2005 · CA
Titanium-gold-based chemotherapeutics for prostate and kidney cancer
$353,250Maria Contel · Brooklyn College · SC1 · FY2013 · CA
TARGETED DELIVERY OF THERAPEUTIC RNA INTO PROSTATE CANCERS
$353,250Cincinnati Univ Of · · FY2010 · Department of the Army
Titanium-gold-based chemotherapeutics for prostate and kidney cancer
$353,250Maria Contel · Brooklyn College · SC1 · FY2016 · CA
Titanium-gold-based chemotherapeutics for prostate and kidney cancer
$353,250Maria Contel · Brooklyn College · SC1 · FY2015 · CA
Targeting MIC shedding to revive host NKG2D-mediated immune response in prostate
$353,238Jennifer D Wu · University Of Washington · R01 · FY2011 · CA
Dynamic, live-cell monitoring of T-cell states against presented peptides
$353,204Jack Hu · Pumpkinseed Technologies Inc · R43 · FY2025 · CA
High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment
$353,192Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · CA
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
$353,173Gary L. Kleiger · University Of Nevada Las Vegas · R01 · FY2023 · GM
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
$353,173Gary L. Kleiger · University Of Nevada Las Vegas · R01 · FY2024 · GM
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
$353,173Gary L. Kleiger · University Of Nevada Las Vegas · R01 · FY2022 · GM
Role of MED1 in the AR-dependent transcription in advanced prostate cancer
$353,134Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2024 · CA
Function of TbRIII as a BMP Co-receptor in Human Cancer
$353,126Gerard C Blobe · Duke University · R01 · FY2011 · CA
Epithelial/stromal signaling in bladder and prostate cell proliferation
$353,120Philip A Beachy · Stanford University · R01 · FY2015 · CA
Pharmcogenomic dissection of mTOR translational targets in prostate cancer
$353,114Davide Ruggero · University Of California, San Francisco · R01 · FY2015 · CA
Computational and Experimental Modeling of Alternative Polyadenylation
$353,100Wei Li · University Of California-Irvine · R01 · FY2023 · CA
Phase III Study of Donepezil in the Irradiated Brain
$353,087Stephen R Rapp · Wake Forest University Health Sciences · R01 · FY2008 · NR
Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs
$353,076Xiumei Huang · Indiana University Indianapolis · R01 · FY2022 · CA
Molecular Determinants of Androgen Receptor Pharmacology
$353,034Donald P McDonnell · Duke University · R01 · FY2009 · CA
Novel multivalent PSMA-targeted taxane-conjugates for bone metastases in prostate cancer
$353,009Sang Van · Paramita Therapeutics, Inc. · R43 · FY2025 · CA
INVESTIGATING THE ROLE OF STROMAL WNT SIGNALING IN ADVANCED PROSTATE CANCER.
$352,962University Of Washington · · FY2020 · Defense Health Agency
MR Guided Focused Ultrasound Surgery for Prostate Cancer
$352,959Brigham And Women'S Hospital · R01 · FY2005 · CA
MDA-7/IL-24: Therapy of Ovarian Cancer
$352,943David T Curiel · Columbia University Health Sciences · P01 · FY2007 · CA